STOCK TITAN

Clorox (CLX) director Russell Weiner receives additional deferred stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Clorox director Russell J. Weiner reported two compensation-related grants of Deferred Stock Units, increasing his deferred equity-based holdings. He acquired 353.6253 Deferred Stock Units on June 30, 2026 and 242.2414 units on May 8, 2026, both recorded at a price of $0.0000 per unit as non-cash awards.

These units correspond 1-for-1 to shares of Clorox common stock and are linked to the company’s Independent Directors' Deferred Compensation Plan through dividend reinvestment and the election to receive quarterly director fees in Deferred Stock Units. After the June award, Weiner directly holds 18,599.8701 Deferred Stock Units, which will be settled entirely in Clorox stock upon his retirement or other termination of service as a director.

Positive

  • None.

Negative

  • None.
Insider WEINER RUSSELL J
Role null
Type Security Shares Price Value
Grant/Award Deferred Stock Units 353.625 $0.00 --
Grant/Award Deferred Stock Units 242.241 $0.00 --
Holdings After Transaction: Deferred Stock Units — 18,599.87 shares (Direct, null)
Footnotes (1)
  1. 1-for-1 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.
June 30, 2026 Deferred Stock Units granted 353.6253 units Non-cash award, grant/award acquisition at $0.0000 per unit
May 8, 2026 Deferred Stock Units granted 242.2414 units Non-cash award, grant/award acquisition at $0.0000 per unit
Deferred Stock Units after June 30, 2026 18,599.8701 units Total direct Deferred Stock Unit holdings following latest grant
Price per Deferred Stock Unit $0.0000 Recorded transaction price for both Deferred Stock Unit grants
Underlying common stock per unit 1-for-1 Each Deferred Stock Unit corresponds to one share of common stock
Deferred Stock Units financial
"Deferred Stock Units acquired through dividend reinvestment during the fiscal year"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Independent Directors' Deferred Compensation Plan financial
"pursuant to the Independent Directors' Deferred Compensation Plan"
A deferred compensation plan for independent directors lets outside board members postpone receiving part of their fees or stock awards until a later date, often when they retire or leave the board. Think of it as choosing to put pay into a company-run savings plan that grows and pays out later; it matters to investors because it affects director incentives, future cash or share obligations, and how aligned independent directors are with long-term company performance.
dividend reinvestment financial
"Deferred Stock Units acquired through dividend reinvestment during the fiscal year"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
quarterly director's fees financial
"Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees"
settled 100% in Clorox stock financial
"The Deferred Stock Units will be settled 100% in Clorox stock"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WEINER RUSSELL J

(Last)(First)(Middle)
1221 BROADWAY

(Street)
OAKLAND CALIFORNIA 94612-1888

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units(1)05/08/2026A(2)V242.2414 (3) (3)Common Stock242.2414$0.000018,246.2448D
Deferred Stock Units(1)06/30/2026A(4)353.6253 (3) (3)Common Stock353.6253$0.000018,599.8701D
Explanation of Responses:
1. 1-for-1
2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.
By Jinho Joo, Attorney-in-Fact07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)